Table 1. . Selected list of recent and current clinical trials for pediatric brain tumors that have incorporated nonsurvival-based end points.
Reference or identifier | Tumor type | Intervention | Nonsurvival end points† | Assessment tool |
---|---|---|---|---|
Hummel et al. [16] | High-grade glioma and diffuse intrinsic pontine glioma | Bevacizumab | QoL | PedsQL |
NCT00085735 (ACNS0331) | Standard-risk medulloblastoma | Radiation and chemotherapy | Neurocognition QoL |
ALTE07C1 PedsQL |
NCT01096368 (ACNS0831) | Ependymoma | Maintenance chemotherapy following induction chemotherapy and radiation therapy | Neurocognition | ALTE07C1 |
NCT01602666 (ACNS1123) | Localized primary CNS germinoma | Chemotherapy followed by radiation | Neurocognition | ALTE07C1 |
NCT02096471 | Plexiform neurofibroma | MEK inhibitor PD-0325901 | QoL | PedsQL-NF1 Module |
†Nonsurvival end points: Quality of life (QoL), neurocognitive or neurological functioning.
QoL: Quality of life.